| Financial Year |
March 31 2023 |
| Monetary Funds |
14,470,804.27 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
8,772,385.12 |
| Accounts Receivable |
142,099,459.53 |
| Advances to Suppliers |
22,755,272.04 |
| Other Receivables |
10,806,259.60 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
156,676,469.12 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
4,924,787.15 |
| Total Current Assets |
388,487,546.18 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
36,942,625.40 |
| Investment Properties |
33,816,917.56 |
| Fixed Assetes |
117,086,865.15 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
92,590,272.66 |
| R&D expenses |
-- |
| Goodwill |
499,898.54 |
| Long-Term Deferred and Prepaid Expenses |
175,000.00 |
| Deferred Income Tax Assets |
-- |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
450,232,911.15 |
| Total Assets |
838,720,457.33 |
| Short-Term Loans |
17,669,802.74 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
131,033,595.31 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
5,512,065.10 |
| Taxes Payable |
15,749,279.99 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
21,873,105.26 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
5,017,662.34 |
| Other Current Liabilities |
26,615,514.57 |
| Sub-Total of Current Liabilities |
364,998,003.42 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
57,442,582.85 |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
76,530,315.78 |
| Total Liabilities |
441,528,319.20 |
| Paid-In Capital(Or Share Stock) |
712,800,000.00 |
| Capital Surplus |
587,304,888.17 |
| Surplus Reserve |
44,974,168.45 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-948,931,919.96 |
| Minority Stockholder's Interest |
-684.14 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
397,192,822.27 |
| Owner's Equity（Stockholder's Equity） |
397,192,138.13 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
838,720,457.33 |
